Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 62289 [patent_doc_number] => 07763251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Kits to assess the risk of tumor progression' [patent_app_type] => utility [patent_app_number] => 11/474144 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23382 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763251.pdf [firstpage_image] =>[orig_patent_app_number] => 11474144 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/474144
Kits to assess the risk of tumor progression Jun 22, 2006 Issued
Array ( [id] => 4999339 [patent_doc_number] => 20070041973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND/OR REVERSING TYPE-1 DIABETES' [patent_app_type] => utility [patent_app_number] => 11/425084 [patent_app_country] => US [patent_app_date] => 2006-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22222 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041973.pdf [firstpage_image] =>[orig_patent_app_number] => 11425084 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/425084
Methods and compositions reversing pre-diabetes using fusion proteins comprising a GAD peptide Jun 18, 2006 Issued
Array ( [id] => 6372658 [patent_doc_number] => 20100080792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen' [patent_app_type] => utility [patent_app_number] => 11/917363 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13160 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080792.pdf [firstpage_image] =>[orig_patent_app_number] => 11917363 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/917363
Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen Jun 14, 2006 Abandoned
Array ( [id] => 5050900 [patent_doc_number] => 20070031445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Compositions and methods for enhancing immune responses mediated by antigen-presenting cells' [patent_app_type] => utility [patent_app_number] => 11/451739 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19636 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031445.pdf [firstpage_image] =>[orig_patent_app_number] => 11451739 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/451739
Compositions and methods for enhancing immune responses mediated by antigen-presenting cells Jun 12, 2006 Abandoned
Array ( [id] => 6280226 [patent_doc_number] => 20100119489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Stimulation of Pancreatic Beta Cell Proliferation' [patent_app_type] => utility [patent_app_number] => 11/921923 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13719 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119489.pdf [firstpage_image] =>[orig_patent_app_number] => 11921923 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/921923
Stimulation of Pancreatic Beta Cell Proliferation Jun 6, 2006 Abandoned
Array ( [id] => 4970757 [patent_doc_number] => 20070110759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Methods' [patent_app_type] => utility [patent_app_number] => 11/434320 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 20483 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110759.pdf [firstpage_image] =>[orig_patent_app_number] => 11434320 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/434320
Methods May 10, 2006 Abandoned
Array ( [id] => 5601782 [patent_doc_number] => 20060292127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Beta cell growth and differentiation' [patent_app_type] => utility [patent_app_number] => 11/429164 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9520 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292127.pdf [firstpage_image] =>[orig_patent_app_number] => 11429164 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/429164
Beta cell growth and differentiation May 4, 2006 Abandoned
Array ( [id] => 5851119 [patent_doc_number] => 20060234310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/415135 [patent_app_country] => US [patent_app_date] => 2006-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4944 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234310.pdf [firstpage_image] =>[orig_patent_app_number] => 11415135 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/415135
Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods Apr 30, 2006 Abandoned
Array ( [id] => 5075234 [patent_doc_number] => 20070015209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease' [patent_app_type] => utility [patent_app_number] => 11/406156 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26361 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015209.pdf [firstpage_image] =>[orig_patent_app_number] => 11406156 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/406156
Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease Apr 17, 2006 Issued
Array ( [id] => 9311272 [patent_doc_number] => 08652488 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Insulin B chain autoantigen composition' [patent_app_type] => utility [patent_app_number] => 11/403580 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13831 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11403580 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/403580
Insulin B chain autoantigen composition Apr 12, 2006 Issued
Array ( [id] => 5921425 [patent_doc_number] => 20060240032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 11/395663 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10486 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240032.pdf [firstpage_image] =>[orig_patent_app_number] => 11395663 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/395663
Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases Mar 29, 2006 Abandoned
Array ( [id] => 8188881 [patent_doc_number] => 08183039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Method for isolating BDCA-4+ dendritic cells' [patent_app_type] => utility [patent_app_number] => 11/393155 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 34498 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183039.pdf [firstpage_image] =>[orig_patent_app_number] => 11393155 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/393155
Method for isolating BDCA-4+ dendritic cells Mar 28, 2006 Issued
Array ( [id] => 5264453 [patent_doc_number] => 20090117138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'VACCINE FOR A THERAPEUTIC OR A PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS' [patent_app_type] => utility [patent_app_number] => 12/294109 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7734 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117138.pdf [firstpage_image] =>[orig_patent_app_number] => 12294109 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/294109
Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis Mar 22, 2006 Issued
Array ( [id] => 5618940 [patent_doc_number] => 20060188473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Compositions and methods for repressing B cell autoantibody secretion and for treating autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 11/376375 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27270 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188473.pdf [firstpage_image] =>[orig_patent_app_number] => 11376375 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376375
Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor Mar 14, 2006 Issued
Array ( [id] => 4909145 [patent_doc_number] => 20080019911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4' [patent_app_type] => utility [patent_app_number] => 11/375297 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5093 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019911.pdf [firstpage_image] =>[orig_patent_app_number] => 11375297 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375297
Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4 Mar 13, 2006 Abandoned
Array ( [id] => 5141327 [patent_doc_number] => 20070003543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Low dose histone peptide treatment for autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 11/373894 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 86 [patent_figures_cnt] => 86 [patent_no_of_words] => 40168 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003543.pdf [firstpage_image] =>[orig_patent_app_number] => 11373894 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/373894
Low dose histone peptide treatment for autoimmune disorders Mar 12, 2006 Abandoned
Array ( [id] => 5564632 [patent_doc_number] => 20090137485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/886482 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10688 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137485.pdf [firstpage_image] =>[orig_patent_app_number] => 11886482 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/886482
Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof Mar 8, 2006 Abandoned
Array ( [id] => 5682958 [patent_doc_number] => 20060199228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Peptides for treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 11/370168 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10889 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199228.pdf [firstpage_image] =>[orig_patent_app_number] => 11370168 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/370168
Peptides for treatment of autoimmune diseases Mar 7, 2006 Abandoned
Array ( [id] => 4682785 [patent_doc_number] => 20080249011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Use of Mgc4504' [patent_app_type] => utility [patent_app_number] => 11/908065 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14710 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249011.pdf [firstpage_image] =>[orig_patent_app_number] => 11908065 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908065
Use of Mgc4504 Mar 5, 2006 Abandoned
Array ( [id] => 5682569 [patent_doc_number] => 20060198839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions' [patent_app_type] => utility [patent_app_number] => 11/367682 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11527 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20060198839.pdf [firstpage_image] =>[orig_patent_app_number] => 11367682 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/367682
Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions Mar 2, 2006 Issued
Menu